Combined Topical Corticosteroid and Topical Cyclosporine-A 0.05% for Management of COVID-19 Keratoconjunctivitis: A pilot study.

Volume 1, Issue 4, December 2021, Pages 189-197

Sherein Mahmoud Hagras; Mona Abdelhamid Nassief; Ameera Gamal Abdelhameed; Omar Khaled Alduwailah

• View Article
• PDF 802.94 K
• View on SCiNiTO